Diagnostic evaluation should follow principle of 'as low as reasonably achievable'; systemic therapy should be deferred until second trimester ...
Dr David Johnson selects his 10 highest-impact publications from 2025, which define new management standards across a broad spectrum of diseases.
This article is sponsored by TeamHealth. In this Voices interview, Skilled Nursing News sits down with Jessica Stone, ...
Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...
New Jersey is poised to become one of the first states on the East Coast to establish a regulated framework for ...
All In Solutions Detox CA LLC Announces Enhanced Clinical Protocols for Safe Detox Center Operations
All In Solutions Detox CA LLC has announced the implementation of enhanced clinical protocols designed to improve patient ...
In clinical practice guidelines issued by the American College of Cardiology and American Heart Association and published ...
Revised version global guidelines on diverticular disease of the colon: the Fiesole Consensus report
Introduction Colonic diverticulosis is the most common structural abnormality of the colon in developed countries, with an increasing global prevalence. Approximately 20–25% of affected individuals ...
Renuka Iyer, M.D., will assume the role of CMO at NCCN, focusing on advancing evidence-based cancer care and guideline ...
The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology have been updated to include duvelisib (Copiktra) as a category 2A treatment option for cutaneous T-cell ...
Correspondence to Dr Roula Kotsifaki, Rehabilitation Department, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Qatar; argyro.kotsifaki{at}aspetar.com This guideline was developed to inform ...
From the start of Phase I to the completion of Phase III, the average clinical trial cycle has been increasing in recent years. Examining figures from the top 20 biopharma companies by R&D spend, data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results